Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Yahoo! Finance
G&A Expenses: $24.0 million for Q3 2024, up from $15.5 million in Q3 2023. Net Loss: $156.3 million for Q3 2024, compared to $108.4 million in Q3 2023. Projected Full Year 2024 GAAP Net Loss: Expected to be between $560 million and $600 million. Non-Cash Stock-Based Compensation Expense: Estimated between $70 million and $80 million for 2024. Warning! GuruFocus has detected 6 Warning Signs with RVMD. Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Revolution Medicines Inc ( NASDAQ:RVMD ) has made substantial progress in advancing its RAS inhibitor portfolio, particularly with RMC 6,236 and RMC 9,805, showing promising results in pancreatic ductal adenocarcinoma (PDAC). The company reported encouraging progression-free survival (PFS) and overall survival (OS) data for RMC 6,236 in metastatic PDAC, with a median PFS of 8.5 months and median OS of 14.5 months. RMC 9,805 demonstrated a 3
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at HC Wainwright from $62.00 to $64.00. They now have a "buy" rating on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Needham & Company LLC from $61.00 to $68.00. They now have a "buy" rating on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at JPMorgan Chase & Co. from $54.00 to $63.00. They now have an "overweight" rating on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Piper Sandler from $57.00 to $70.00. They now have an "overweight" rating on the stock.MarketBeat
RVMD
Earnings
- 11/6/24 - Miss
RVMD
Sec Filings
- 11/19/24 - Form 4
- 11/15/24 - Form 144
- 11/15/24 - Form 4
- RVMD's page on the SEC website